Pyotr Bely at the council "Protection against COVID-19: measures against the new coronavirus infection"

06.08.2021

Industry development

Peter Bely, Chairman of the Board of Directors of Promomed Group, took part in the consultation "Protection from COVID-19: measures against the new coronavirus infection". The participants of the meeting, representatives of the medical and pharmaceutical communities, shared their experience of specific solutions and exchanged proposals for improving efficiency in all areas of the fight against the pandemic.
In his speech, Peter Bely focused on aspects of etiotropic and pathogenetic therapy. He invited the participants to join the educational work to overcome the conservative perception of innovative medicines by patients, noting the importance of early initiation of therapy and following the patient's doctor's recommendations and medical protocols.
The speaker also drew attention to the importance of widely applying the lessons and experience of the pandemic.: "Russia has managed to create a well-organized system of drug supply in a short time, which has shown very good results. This became possible thanks to the efforts of the Ministry of Health, the Government as a whole, the medical community led by the academic consortium and the pharmaceutical industry. A unique regulatory mechanism was created and implemented - without reducing the volume of clinical trials or pharmaceutical expertise, it was possible to significantly shorten the time for the development and registration of innovative pharmaceutical products."
Based on the successful experience that led to the emergence and continued emergence of innovative drugs for the treatment of covid-19, Peter Bely proposed to extend the best practices of regulatory work to other areas.
For example, domestic innovative drugs aimed at other nosologies that carry the greatest mortality, including cancer and diabetes. "In this case, Russia, as an industrial country that creates innovative drugs, will receive well-deserved recognition as a global supplier of innovative solutions for the most important therapeutic products," added Peter Bely.
The event was held on August 05, 2021, under the moderation of Denis Protsenko, Chief Physician of GBUZ City Clinical Hospital No. 40, with the participation of heads of the largest hospitals in Moscow and the regions, representatives of the Ministry of Health of the Russian Federation, Rospotrebnadzor, and public organizations.

Get the most interesting news and publications first!

Sent successfully!

Pharmacovigilance

Press office

To request a press release or interview, please contact our press office